Poolbeg Pharma moves forward with oral vaccine programme
Poolbeg Pharma, a clinical-stage biopharma company focusing on infectious and other prevalent diseases with high unmet medical needs, has announced an update to its oral vaccine programme.
Poolbeg Pharma, a clinical-stage biopharma company focusing on infectious and other prevalent diseases with high unmet medical needs, has announced an update to its oral vaccine programme.
Unquestionably, the buzzword of 2023 is artificial intelligence (AI). From ChatGPT-4 preparing to revolutionize online research to IBM’s project debater engaging humans in live debates, it’s clear that we stand at the dawn of a new era of assistive and...